|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Pharmaceuticals in France |
|
|
|
|
€ 198,00 |
Editeur
: |
Euromonitor |
Langue
: |
Anglais |
Date de publication : |
Septembre 2002 |
Taille du document : |
15 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 86 pages | Août 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,pharmacovigilance
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,united kingdom,india,germany,thailand,nigeria,... |
| |
|
|
|
|
| 96 pages | Juillet 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...,banks
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,china,france,canada,bermuda,israel,japan,india,... |
| |
|
|
|
|
| 64 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,atherosclerosis,hypertension
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada |
| |
|
|
|
|
| 64 pages | Novembre 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,dyslipidemia,pharmaceutical,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada,poland |
| |
|
|
|
|
| 70 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
india,usa,china,france,united kingdom,malaysia,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic |
3 500,00 €
|
| |
| |
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
188 pages | Septembre 2001 |
Global Parallel Trade Outlook 2001: A country-by-country analysis, a new report by Reuters Business Insight, provides a detailed update on the status of parallel trade in the global marketplace.
1 200,00 €
|
|
| |
| |
Antisense Therapy: Technical Aspects and Commercial Opportunities
334 pages | Mars 2000 |
Antisense therapy interferes with the expression of disease-causing proteins, thus offering a direct and selective intervention in the disease process.
Besides the well known oligonucleotides ( |
955,00 €
|
| |
| |
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth
173 pages | Mars 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once near unrestricted revenue expansion existed, external pressures now act in unison |
955,00 €
|
| |
| |
Regulatory Affairs: Paths to Approval
113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio |
795,00 €
|
| |
| |
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs
119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike.
A great need exists for ph |
795,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Pfizer's Recent Takeover
15 pages | Juillet 2002 |
On 15th July 2002, Pfizer announced the acquisition of Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care.
|
300,00 €
|
| |
| |
Top Ten and Emerging Pharmaceutical markets
214 pages | Juillet 1999 |
Introduction : Provides the background to the report by identifying the major trends within global healthcare markets and how these interact and influence the markets for pharmaceuticals.
Mar |
795,00 €
|
| |
| |
The Pharmaceutical Mergers and Acquisitions Outlook 2001
128 pages | Octobre 2001 |
Pharmaceutical companies have recently undertaken extensive M&A activity to either build critical mass, create organic growth or through strategic alliances to build virtual mass.
The Pharmaceu |
1 200,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Pharmaceuticals in France |
|
|
The French market for pharmaceuticals grew by 5.4% in 2001 to reach a value of Euro17.7 billion (US$16.7 billion). The market grew by 24.8% over the review period. In 2000, per capita expenditure a year on pharmaceutical products in France was Euro 412 compared to Euro 372 in 2000, which is the highest level of consumption in Europe, more than double that of the UK. This report is part of Euromonitor’s highly successful Major Market Profiles series. These briefings provide concise, up-to-date, accurate and affordable analysis of 156 commercial, industrial and service sectors in France, Germany, the UK and the US.
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Competitive Landscape 12
CHAPTER 6 Leading Companies 14
6.1 Sanofi-Aventis Group 14
6.2 Bristol-Myers Squibb Company 14
6.3 GlaxoSmithKline Plc 15
6.4 Eli Lilly and Company 15
6.5 E. I. duPont de Nemours & Company 16
6.6 Merck & Co., Inc. 16
CHAPTER 7 Market Forecasts 17
7.1 Market Value Forecast 17
CHAPTER 8 Macroeconomic Indicators 18
CHAPTER 9 Further Reading 20
9.1 Sources 20
9.2 Related Datamonitor Research 20
LIST OF TABLES
Table 1: France Pharmaceuticals Market Value: $ billion, 2001-2005 9
Table 2: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2005 10
Table 3: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2005 11
Table 4: France Pharmaceuticals Market Value Forecast: $ billion, 2005-2010 17
Table 5: France Size of Population (million) , 2001-2005 18
Table 6: France GDP (1995=100), 2001-2005 18
Table 7: France Inflation, 2001-2005 18
Table 8: France Exchange Rate, 2001 19
??
??
??
??
CONTENTS
|
|
|
PPLSEN
|
|
|
|
|
